ImageIQ is customizing the 3-D technology for the Rutgers study. It will create 3-D data and images of the material, scaffold, and tissue, which it will use to evaluate new bone growth in and around the scaffold. The company will also create and validate bone growth performance metrics. “We have a great deal of experience in applying 3-D imaging and image analytics to improve bone tissue scaffold R&D timelines, reduce costs and enhance study end points and performance measurements,” said Amit Vasanji, PhD, chief technology officer at ImageIQ, in a press release. “For this particular study, our utilization of custom-tailored Micro-CT imaging and image analysis will give the research team greater insight into how their scaffold and biomaterial are performing. The team will be able to assess which end point measurements can reliably translate to a clinical study.”

 

The biomaterial scaffold has potential to help soldiers and civilians who have large bone defects, nonunion fractures, or suffer from severe bone loss.